Sulfonated zwitterionic molecules with heterocycles for biofunctional applications
Novel sulfonated zwitterionic molecules featuring heterocyclic rings that mimic biofunctional properties of compounds like glyphosate. These molecules combine zwitterionic behavior in aqueous solution with hydrophobic ring structures, offering potential applications in agrochemicals, pharmaceuticals, and biofunctional materials.
Overview
This research explores sulfonated zwitterionic molecules incorporating heterocyclic rings as a new class of biofunctional compounds. The molecules share structural similarities with known biofunctional agents such as glyphosate, exhibiting zwitterionic behavior in aqueous environments while featuring hydrophobic ring structures essential for biological activity. This dual characteristic makes them promising candidates for applications in agrochemicals, pharmaceutical development, and specialty biofunctional materials.
The research hypothesis is grounded in the observation that combining zwitterionic functionality with hydrophobic heterocycles can produce molecules with tailored biological interactions. This approach leverages established structure-activity relationships while exploring novel molecular architectures.
Technical specifications
Key molecular features:
- Zwitterionic character in aqueous solution, enabling pH-responsive behavior and enhanced solubility
- Heterocyclic ring structures providing hydrophobic interactions critical for biofunctional activity
- Sulfonation as a functional group contributing to ionic character and potential for further chemical modification
- Structural analogy to glyphosate and related biofunctional compounds
Potential applications:
- Agrochemical development, including herbicide and pesticide formulations
- Pharmaceutical intermediates and active ingredient research
- Biofunctional materials requiring controlled hydrophobic-ionic balance
- Specialty chemicals for industrial biotechnology
Technology readiness level
This research is at an early discovery stage, with the hypothesis based on structural similarities to known biofunctional molecules. Further validation through synthesis, characterization, and biological testing is needed to confirm efficacy and explore specific application domains. The work represents foundational research that could lead to optimized molecular designs for targeted biofunctional applications.
About Florida Institute of Technology
Florida Institute of Technology is a private, doctoral‑granting, research‑intensive technological university in Melbourne on Florida’s Space Coast. Industry collaboration is anchored by the Vertex Applied Innovation Hub, offering co‑location through a business‑in‑residence program, contract R&D, and access to advanced prototyping and digital engineering resources, alongside targeted workforce development. A structured co‑op program and employer‑hosted externships connect companies with faculty and student talent year‑round, amplified by proximity to the region’s aerospace and defense cluster. Research is supported by competitive federal funding, including the National Science Foundation and NASA. Clear IP policies and university support streamline collaboration terms and commercialization pathways.
Inquire about this partnering listing
Looking for
delivered to your inbox.